Skip to main content
Edit Page - Admin Only Style Guide - Admin Only Control Panel - Admin Only
pharmaceutical-medical-device

Pharmaceuticals & Medical Devices

Leading global law firms turn to IMS when a drug or device is at the center of product liability, mass tort, intellectual property, or antitrust litigation. With verdicts rising and public safety concerns under scrutiny, bet-the-company disputes put a manufacturer's finances and reputation on trial. IMS helps litigation teams reduce risk, from early case assessment through trial and appeal.

Reduce risks and discover creative solutions for complex disputes.

Drug and device cases require adjudicators to weigh general and specific causation, FDA labeling decisions, and years of event data. A bellwether verdict can set the value of thousands of cases, making Daubert and Rule 702 preparation, preemption arguments, and the positioning of manufacturers' internal documents the first steps in our approach to developing a strategic roadmap for clients to reduce litigation risk.

IMS brings decades of experience supporting both sides of some of the most significant decisions in pharmaceutical and medical device disputes. We work with legal teams on behalf of brand and generic drug makers, medical device and implant manufacturers, distributors, and the patients and payers bringing these claims. Representative dispute types include:

  • Product liability: design defect, manufacturing defect, and failure to warn
  • Mass tort MDLs, bellwether trials, and consumer class actions
  • Medical device and implant failures, recalls, and FDA 483 or warning letter disputes
  • Off-label promotion, False Claims Act, and qui tam actions
  • Patent infringement, trade secret, and licensing disputes
  • Antitrust, drug pricing, and reverse-payment (pay-for-delay) claims
  • False advertising and Lanham Act claims

Am Law and boutique firms nationwide rely on IMS for credible, non-conflicted experts to weigh consumer perception, credible data on how jurors view the case issues, and cohesive strategies that strengthen the case throughout the lifecycle of a claim, whether in MDL courts, state coordinated proceedings, federal and state trials, or arbitration. Read more below.

Over the course of nearly three decades, I have worked with many trial support firms. IMS is far and away the best. I can’t imagine trying a case without IMS as part of my trial team.

Senior Counsel, Am Law 50 Firm

IMS brought me top, non-conflicted experts (in a very narrow field that is rife with conflict issues) in a short period of time. I was impressed with their approach and attention to my needs.

Litigation Managing Partner

FAQs

IMS is retained in pharmaceutical and medical device litigation including product liability claims for design defect, manufacturing defect, and failure to warn; mass tort MDLs, bellwether trials, and class actions; device failures and recalls; off-label promotion and False Claims Act actions; patent, trade secret, and licensing disputes; antitrust and pay-for-delay claims; and false advertising under the Lanham Act.

The nature of causation science requires FDA regulatory history, and engineering evidence that must survive Daubert and Rule 702 challenges and persuade a jury. Expert witnesses supply credible testimony that adjudicators rely on, while litigation consultants help trial teams measure juror sentiment on key issues, witness credibility, and case narratives.

In such a small industry, experts frequently consult for manufacturers or regulators, so conflicts are common. Our custom search team screens candidates for conflicts and prior testimony, and has placed bioengineers, toxicologists, epidemiologists, physicians, FDA regulatory specialists, and supply chain experts on tight timelines.

IMS conducts legal research in the trial venue, develops consistent themes from one bellwether to the next, guides voir dire, builds medical and regulatory demonstratives, and deploys hot seat operators to ensure smooth courtroom delivery. Our economists and statisticians, and consumer science experts conduct reliable research to support class certification and damages analysis.

IMS regulatory experts address 510(k), PMA, and drug approval pathways, and our trial graphics and demonstrative team builds interactive timelines and other cutting-edge visuals that show approval, labeling changes, adverse event reports, and recalls in context.

IMS sources technical and prior art experts for patent infringement and validity disputes in federal court, before the PTAB, and at the ITC, alongside damages experts and visual advocacy for trial.